Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
48,121
+374
+0.8% +$9.78K 0.04% 135
2026
Q1
$1.34M Sell
47,747
-64
-0.1% -$1.7K 0.05% 126
2025
Q4
$1.19M Sell
47,811
-363
-0.8% -$9.15K 0.05% 131
2025
Q3
$1.23M Buy
48,174
+59
+0.1% +$1.46K 0.05% 127
2025
Q2
$1.17M Sell
48,115
-136,684
-74% -$3.19M 0.06% 121
2025
Q1
$4.68M Buy
184,799
+20,486
+12% +$536K 0.26% 48
2024
Q4
$4.36M Sell
164,313
-7,720
-4% -$209K 0.24% 45
2024
Q3
$4.98M Sell
172,033
-6,314
-4% -$184K 0.29% 39
2024
Q2
$4.99M Buy
178,347
+6,766
+4% +$186K 0.31% 41
2024
Q1
$4.76M Buy
171,581
+2,622
+2% +$72.8K 0.32% 42
2023
Q4
$4.86M Buy
168,959
+14,419
+9% +$436K 0.36% 42
2023
Q3
$5.13M Buy
154,540
+27,868
+22% +$985K 0.43% 39
2023
Q2
$4.65M Buy
126,672
+4,197
+3% +$163K 0.39% 43
2023
Q1
$5M Buy
122,475
+7,106
+6% +$307K 0.46% 37
2022
Q4
$5.91M Buy
115,369
+10,658
+10% +$511K 0.58% 31
2022
Q3
$4.58M Sell
104,711
-42,197
-29% -$2.05M 0.5% 36
2022
Q2
$7.7M Buy
146,908
+5,027
+4% +$256K 0.83% 18
2022
Q1
$7.35M Sell
141,881
-705
-0.5% -$36.6K 0.71% 23
2021
Q4
$8.42M Buy
142,586
+2,664
+2% +$132K 0.82% 19
2021
Q3
$6.02M Buy
+139,922
New +$6.2M 0.78% 19

Other funds holding PFE

JB Capital's PFE Position: Q2 2026 in Review

JB Capital increased its Pfizer (PFE) stake by 0.78% in Q2 2026, buying an estimated $9.78K and bringing the position to 48,121 shares worth $1.16M. The position accounts for 0.04% of the portfolio, ranked #135.

JB Capital first reported a position in PFE in Q3 2021 and has held it in 20 quarters since. The position peaked at $8.42M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • JB Capital held 48,121 shares of Pfizer worth $1.16M as of Q2 2026.
  • JB Capital bought 374 Pfizer shares in Q2 2026, an estimated $9.78K.
  • Pfizer made up 0.04% of JB Capital's portfolio in Q2 2026, its #135 holding.
  • JB Capital first reported a position in Pfizer in Q3 2021 and has held it in 20 quarters since.
  • JB Capital's Pfizer position peaked at $8.42M in Q4 2021.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on JB Capital's 13F filing for Q2 2026, filed 29 Jul 2026.